Telemedicine for screening diabetic retinopathy: The NO BLIND Italian multicenter study

Diabetes/Metabolism Research and Reviews

Volumn 35, Issue 3, 2019, Pages

  Sasso, Ferdinando Carlo ^a   Pafundi, Pia Clara ^a   Gelso, Aldo ^b   Bono, Valeria ^c   Costagliola, Ciro ^d   Marfella, Raffaele ^a   Sardu, Celestino ^a   Rinaldi, Luca ^a   Galiero, Raffaele ^a   Acierno, Carlo ^a   de Sio, Chiara ^e   Adinolfi, Luigi Elio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Private Hospital Villa Dei Fiori Srl Accredited to National Health System   (Italy)

^c IRCCS FONDAZIONE BIETTI   (Italy)

^d UNIVERSITY OF MOLISE   (Italy)

^e NONE

Author keywords

cost effectiveness; diabetic retinopathy; observational study; screening

Indexed keywords

ADULT; AGED; ARTICLE; DIABETIC RETINOPATHY; DIABETOLOGIST; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EYE FUNDUS; FEMALE; HUMAN; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPHTHALMOSCOPY; PILOT STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETINOGRAPHY; SCREENING; SENSITIVITY AND SPECIFICITY; TELEMEDICINE; CLINICAL TRIAL; COMPLICATION; EPIDEMIOLOGY; FOLLOW UP; ITALY; MASS SCREENING; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROGNOSIS;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; ITALY; MALE; MASS SCREENING; MIDDLE AGED; PILOT PROJECTS; PREVALENCE; PROGNOSIS; TELEMEDICINE;

EID: 85059630904     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.3113     Document Type: Article

References (34)

1. Das A. Diabetic retinopathy: battling the global epidemic. Invest Ophthalmol Vis Sci. 2016;57(15):6669-6682. https://doi.org/10.1167/iovs.16-21031.
2. Yau JW, Rogers SL, Kawasaki R, et al. On behalf of the meta-analysis for eye disease (META-EYE) study group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556-564. https://doi.org/10.2337/dc11-1909. Epub 2012 Feb 1.
3. AMD-SID - Standard italiani per la cura del Diabete mellito 2018
4. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy II prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520-526.
5. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, et al. Effect of intensive glucose lowering treatment on all-cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. Br Med J. 2011;343(jul26 1):d4169. https://doi.org/10.1136/bmj.d4169.
6. Hemmingsen B, Lund SS, Gluud C, et al. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ. 2011;343(nov24 1):d6898. https://doi.org/10.1136/bmj.d6898.
7. Chalk D, Pitt M, Vaidya B, Stein K. Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy? Diabetes Care. 2012;35(8):1663-1668. https://doi.org/10.2337/dc11-2282. Epub 2012 May 7.
8. Scanlon PH, Aldington SJ, Leal J, et al. Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Health Technol Assess. 2015;19(74):1-116. https://doi.org/10.3310/hta19740.
9. Salongcay RP, Silva PS. The role of teleophthalmology in the management of diabetic retinopathy. Asia Pac J Ophthalmol (Phila). 2018;7(1):17-21. https://doi.org/10.22608/APO.2017479. Epub 2017 Jan 26.
10. Phan A-DT, Koczman JJ, Yung C-W, Pernic AA, Doerr ED, Kaehr MM. Cost analysis of tele-retinal screening for diabetic retinopathy in a county hospital population. Diabetes Care. 2014;37(12):e252-e253. https://doi.org/10.2337/dc14-0929.
11. Zimmer-Galler IE, Kimura AE, Gupta S. Diabetic retinopathy screening and use of telemedicine. Curr Opin Ophthalmol. 2015;26(3):167-172. https://doi.org/10.1097/ICU.0000000000000142
12. Jani PD, Forbes L, Choudhury A, Preisser JS, Viera AJ, Garg S. Evaluation of diabetic retinal screening and factors for ophthalmology referral in a telemedicine network. JAMA Ophthalmol. 2017 Jul;135(7):706-714. https://doi.org/10.1001/jamaophthalmol.2017.1150
13. Cruciani F, Amore F, Albanese G, Anzidei R. Investigation about causes of blindness and low vision among members of blind and visually impaired Italian union (UICI). Clin Ter. 2011;162(2):e35-e42.
14. Tran TH, Rahmoun J, Hui Bon Hoa AA, et al. Screening for diabetic retinopathy using a three-field digital nonmydriatic fundus camera in the north of France. J Fr Ophtalmol. 2009 Dec;32(10):735-741. https://doi.org/10.1016/j.jfo.2009.10.015.[ArticleinFrench]
15. Szabó D, Fiedler O, Somogyi A, et al. Telemedical diabetic retinopathy screening in Hungary: a pilot programme. J Telemed Telecare. 2015 Apr;21(3):167-173. https://doi.org/10.1177/1357633X15572712. Epub 2015 Feb 22
16. Schulze-Döbold C, Erginay A, Robert N, Chabouis A, Massin P. Ophdiat(®): five-year experience of a telemedical screening programme for diabetic retinopathy in Paris and the surrounding area. Diabetes Metab. 2012 Nov;38(5):450-457. https://doi.org/10.1016/j.diabet.2012.05.003. Epub 2012 Jul 4
17. Scanlon PH. The English National Screening Programme for diabetic retinopathy 2003-2016. Acta Diabetol. 2017 Jun;54(6):515-525. https://doi.org/10.1007/s00592-017-0974-1
18. Bruno G, Bonora E, Miccoli R, et al. SID-CINECA ARNO working group. Quality of diabetes care in Italy: information from a large population-based multiregional observatory (ARNO diabetes). Diabetes Care. 2012;35(9):e64. https://doi.org/10.2337/dc12-0765.
19. Osservatorio ARNO Diabete. Il profilo assistenziale della popolazione con diabete. Rapporto 2015. Volume XXIII – Collana “Rapporti ARNO”. http://osservatorioarno.cineca.org)
20. Porta M, Boscia F, Lanzetta P, Mannucci E, Menchini U, Simonelli F. Systematic screening of Retinopathy in Diabetes (REaD project): an Italian implementation campaign. Eur J Ophthalmol. 2017 Mar 10;27(2):179-184. https://doi.org/10.5301/ejo.5000912. Epub 2016 Nov 21
21. Marchesini G, Forlani G, Rossi E, Berti A, De Rosa M. ARNO working group. The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatory. Nutr Metab Cardiovasc Dis. 2011;21(5):339-344. https://doi.org/10.1016/j.numecd.2009.10.009. Epub 2010 Feb 13.
22. American Academy of Ophthalmology Retina-Vitreous Panel. Preferred Practice Pattern® Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2017 Available at: www.aao.org/ppp.
23. Semeraro F, Cancarini A, Dell Omo R, Rezzola S, Romano MR, Costagliola C. Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res. 2015;2015:582060. https://doi.org/10.1155/2015/582060. Epub 2015 Jun 7-582016.
24. Semeraro F, Parrinello G, Cancarini A, et al. Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabetes Complications. 2011;25(5):292-297. https://doi.org/10.1016/j.jdiacomp.2010.12.002. Epub 2011 Feb 21.
25. Hautala N, Aikkila R, Korpelainen J, et al. Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. Acta Ophthalmol. 2014;92(6):582-587. https://doi.org/10.1111/aos.12278. Epub 2013 Oct 17
26. Kirkizlar E, Serban N, Sisson JA, Swann JL, Barnes CS, Williams MD. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology. 2013;120(12):2604-2610. https://doi.org/10.1016/j.ophtha.2013.06.029. Epub 2013 Sep 29
27. Vujosevic S, Pucci P, Casciano M, et al. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy. J Diabetes Complications. 2017;31(8):1348-1353. https://doi.org/10.1016/j.jdiacomp.2017.04.010. Epub 2017 Apr 13.
28. Invernizzi A, Bevilacqua MT, Cozzi M, et al. Diabetic retinopathy screening: the first telemedical approach in an Italian hospital. Eur J Ophthalmol. 2016;26(4):369-374. https://doi.org/10.5301/ejo.5000719. Epub 2015 Dec 14
29. American Diabetes Association. Standards of medical Care in Diabetes 2018. Microvascular complications and foot care. Diabetes Care. 2018 Jan;41(Supplement 1):S105-S118. https://doi.org/10.2337/dc18-S010
30. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1989;107(2):237-243.
31. Silva PS, Cavallerano JD, Aiello LM, Aiello LP. Telemedicine and diabetic retinopathy: moving beyond retinal screening. Arch Ophthalmol. 2011;129(2):236-242. https://doi.org/10.1001/archophthalmol.2010.365.
32. Mohammadpour M, Heidari Z, Mirghorbani M, Hashemi H. Smartphones, tele-ophthalmology, and VISION 2020. Int J Ophthalmol. 2017;10:1909-1918. https://doi.org/10.18240/ijo.2017.12.19. eCollection 2017
33. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-787. https://doi.org/10.1038/414782a.
34. Labiris G, Panagiotopoulou EK, Kozobolis VP. A systematic review of teleophthalmological studies in Europe. Int J Ophthalmol. 2018;11(2):314-325. https://doi.org/10.18240/ijo.2018.02.22.eCollection2018.